ProQR Therapeutics

Drug discovery can be slow and patients are waiting. Our CEO Daniel de Boer and Ginkgo CEO Jason Kelly sat together to discuss how our collaboration is accelerating our #Axiomer #RNAEditing platform development. #Biotech #AI

Following our partnership announcement with @Ginkgo Bioworks, our CEO Daniel de Boer sat down with Ginkgo CEO Jason Kelly to discuss the opportunity ahead. Hear how our #Axiomer #RNAEditing platform, automation, and data can accelerate drug development. #Biotech #AI

Today we highlighted key updates in our Investor and Analyst event titled, “Expanding the Axiomer™ RNA Editing Opportunity Beyond AX-0810.” Check out the PR for more details: bit.ly/4tEAbXC and watch the replay of the event: bit.ly/3PZBL7N #Axiomer #Biotech

In one hour, at 10:00 ET, we are hosting a virtual Investor and Analyst event titled, “Expanding the Axiomer™ RNA Editing Opportunity Beyond AX-0810”. For additional information about the event and to register, visit: lifescievents.com/event/g09gufqy… #Axiomer #RNAEditing

We’re excited to introduce our partnership with Ginkgo Bioworks and in addition our AI Advisory Board, helping to bring #Axiomer #RNAEditing therapies to patients faster. Learn more at our Virtual Investor & Analyst event today at 10:00 ET: lifescievents.com/event/g09gufqy…

On April 8th at 10:00 am ET, we are hosting a virtual Investor and Analyst event titled, “Expanding the Axiomer™ RNA Editing Opportunity Beyond AX-0810”. For additional information about the event and to register, visit: lifescievents.com/event/g09gufqy… #Axiomer #RNAEditing

Today we released our 2025 year end financial results and provided a business update. Read the full press release on our website: bit.ly/46V5zIv $PRQR #Biotech #Axiomer #RNAEditing

Driven by a deep curiosity about molecular biology, Seda translates emerging science into strategic direction as Senior Director, Research Strategy & Innovation at ProQR. Explore Seda’s profile on our website: bit.ly/4aZHott #RNAEditing #Axiomer

At #TIDESAsia in Tokyo, our Chief Scientific Officer, Gerard Platenburg, shared how we are translating #Axiomer #RNAEditing into liver and CNS applications. You can explore the presentation here: bit.ly/4aCHSH6

Today we recognize the 11th anniversary of International Day of Women and Girls in Science! We caught up with Cristina Lopez Lopez, MD, PhD, CMO at ProQR, who shared her message for aspiring #WomenInScience. #IDWGS2026 #Feb11 #EveryVoiceInScience

Check out the full PR here: bit.ly/4qtCPNZ

Today, ProQR announced that Dinko Valerio, a co-founder of the Company, and Alison Lawton will rotate off the Board at the Company’s next AGM as their terms conclude. We'd like to sincerely thank Dinko and Alison for their valuable contributions to ProQR during their tenures.

Carles is a Researcher at ProQR, combining a passion for biology with hands-on #RNAEditing research. Beyond the lab, he actively supports an inclusive and welcoming culture as part of the DEI team! Meet more members of the ProQR team: bit.ly/3M09Gvm #Axiomer #TeamProQR

Check out the full PR here: bit.ly/4qcxvzb #Axiomer #RNAEditing

Proud to share our latest update highlighting encouraging initial safety and PK data with AX-0810 (cholestatic diseases), Development Candidate selection for AX-2402 (Rett syndrome) and AX-2911 (MASH), and strong momentum heading into 2026 as we advance our #Axiomer platform.

Our recent edition of the Axiomer Summit brought insightful discussions, a dynamic poster session, and exciting platform updates. Thanks to our SAB and Board for their valuable contributions! #RNAEditing #Axiomer #Biotech

Great to connect with the community at #TIDESEU in Basel last week. Gerard Platenburg, our Chief Scientific Officer, presented on translating #Axiomer RNA Editing science into targeted CNS applications. Check out the presentation here: bit.ly/3K2y927 #RNAEditing

The replay of our Investor and Analyst Event is now available:  bit.ly/43PqFWS Thanks to Professor Verkade for joining us! We are delighted that AX-0810 progressing to the clinic. #Axiomer #RNAEditing $PRQR

Join us in 60 mins for our virtual Investor and Analyst Event with ProQR Management and KOL Prof. Henkjan Verkade, MD, PhD (UMC Groningen). Register for the event here: bit.ly/3Lb7GzE #Axiomer #RNAEditing $PRQR

Join us Nov 3 at 10:00 ET for our virtual Investor and Analyst Event with the ProQR Management and KOL Prof. Henkjan Verkade, MD, PhD (UMC Groningen). Register for the event here: bit.ly/3Lb7GzE #Axiomer #RNAEditing